Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Monday 12 February 2018

Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

Eric Morand et al. published in Annals of the Rheumatic Diseases.

Read article here.

No comments:

Post a Comment